ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
22/04/2026
Voltar para busca
Dado oficial do USPTO
AKAMIS BIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
23/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 42
Data de depósito
04/03/2023
Data de registro
05/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/11/2024
Última transação
23/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
03
Localização do titular
CAMBRIDGE, MA, US
Examinador
JARAMILLO, JAVIER R
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized wording "AKAMIS BIO" to the right of a design consisting of a circle containing a hexagon with a curving paint brushstroke to the upper left.
Titulares e representantes
Titulares
AKAMIS BIO, INC.
Akamis Bio Limited
Representantes
Brian J. Focarino Cooley LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; biotechnological preparations for the medical treatment of solid tumors; biotechnological preparations for the treatment of oncological diseases and disorders
Classe 35
Marketing services in the field of pharmaceutical products; product marketing services in the field of pharmaceutical products; market research in the field of pharmaceutical products; market forecasting in the field of pharmaceutical products; market evaluation servicesmarket analysis and research services in the field of pharmaceutical products; online retail and wholesale store services for pharmaceutical products; online retail and wholesale store services for pharmaceutical preparations; advisoryinformation and consultancy services relating to the aforementioned services
Classe 42
Pharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development service; pharmaceutical research; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; scientific and medical research in the nature of genome organization and functional analysis; genetic testing for scientific research purposes; research and development services in the field of immunologybiotechnologyoncologymedicinegene therapyimmunotherapy and therapeutics; technological consulting servicesproduct development consultation relating to the manufacture of pharmaceuticals; technological consulting servicesproduct development consultation relating to the design of manufacturing methods for pharmaceuticals; advisoryinformation and consultancy services relating to the aforementioned services
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/02/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/02/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/02/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/08/2024
PUBO
PUBLISHED FOR OPPOSITION
20/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
17/07/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/07/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
17/07/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/07/2024
ALIE
ASSIGNED TO LIE
16/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/12/2023
GNRT
NON-FINAL ACTION E-MAILED
11/12/2023
CNRT
NON-FINAL ACTION WRITTEN
11/12/2023
DOCK
ASSIGNED TO EXAMINER
01/12/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
27/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/09/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/09/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
25/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/03/2023
NWAP
NEW APPLICATION ENTERED
08/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AKAMIS BIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.